[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 24, Issue 4 (12-2022) ::
J Gorgan Univ Med Sci 2022, 24(4): 85-90 Back to browse issues page
Prevalence of Ventilator-Associated Pneumonia and Evaluation of Serum C-Reactive Protein, Hemoglobin, and Procalcitonin Levels as their Biomarkers Among Brain Trauma Patients in 5th Azar Hospital, Gorgan, Iran
Seiede Roya Mousavi1 , Mansour Deylami 2, Ramin Azarhoush3 , Arazberdi Ghourchaei4 , Kazem Kazemnejad4 , Seyedbabak Mojaveraghili1 , Seyedeh Mahrokh Alinaghimaddah1 , Seied Amirhassan Mousavi5
1- Assistant Professor , Department of Anesthesiology, Medical School, Golestan University of Medical Sciences, Gorgan, Iran.
2- Assistant Professor , Department of Anesthesiology, Medical School, Golestan University of Medical Sciences, Gorgan, Iran. , mansour.deylami@gmail.com
3- Associate Professor, Department of Pathology, Medical School, Golestan University of Medical Sciences, Gorgan, Iran.
4- Associate Professor , Department of Anesthesiology, Medical School, Golestan University of Medical Sciences, Gorgan, Iran.
5- Pharmacist, Faculty of Pharmaceutical Science, Tehran Branch, Islamic Azad University, Tehran, Iran.
Abstract:   (946 Views)
Background and Objective: Ventilator-associated pneumonia (VAP) is an important complication in intensive care unit (ICU) patients with endotracheal intubation. Finding potential early indicators of this condition can aid in reducing the disease burden. We aimed to investigate the relationship between VAP occurrence and serum levels of C-reactive protein (CRP), procalcitonin (PCT), and hemoglobin (Hgb) during ICU hospitalization of brain trauma patients.
Method: This descriptive-analytical study was carried out on brain trauma patients (99 male, 39 female), referring to the 5th Azar hospital in Gorgan, Iran, in the course of 2017. The patients were hospitalized in ICU with endotracheal intubation and mechanical ventilation. The diagnosis of VAP was confirmed by a 12-score rating based on chest radiographs, body temperature, white blood cell count, and sputum culture. After admission, serum CRP, PCT, and Hgb were documented daily for 6 days.
Results: According to the diagnostic criteria, VAP was confirmed in 41 patients (30%). Serum CRP and PCT levels on the 6th-day post-admission were significantly associated with VAP diagnosis, while Hgb levels did not differ significantly between VAP and non-VAP patients. Serum levels of CRP, PCT, and Hgb on the 6th day were not associated with age or sex.
Conclusion: Our results indicate that serum CRP and PCT levels are associated with the occurrence of VAP in ICU patients receiving mechanical ventilation. Therefore, these biomarkers could be utilized to warn physicians about the possibility of VAP, thereby reducing mortality rate and hospitalization length.

 
Keywords: Pneumonia Ventilator-Associated [MeSH], Procalcitonin [MeSH], C-Reactive Protein [MeSH], Hemoglobin [MeSH]
Article ID: Vol24-55
Full-Text [PDF 683 kb]   (3935 Downloads)    
Type of Study: Original Articles | Subject: Anesthesiology and Pain
References
1. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005 Oct; 33(10): 2184-93. doi: 10.1097/01.ccm.0000181731.53912.d9 [DOI] [PubMed]
2. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010 May; 340: c2096. doi: 10.1136/bmj.c2096 [DOI] [PubMed]
3. Pepys MB. C-reactive protein fifty years on. Lancet. 1981 Mar; 1(8221): 653-57. doi: 10.1016/s0140-6736(81)91565-8 [DOI] [PubMed]
4. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb; 265(3): 621-36. doi: 10.1042/bj2650621 [DOI] [PubMed]
5. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 1996 Nov; 174(5): 994-1000. doi: 10.1093/infdis/174.5.994 [DOI] [PubMed]
6. Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J. 2008 Sep; 32(3): 726-32. doi: 10.1183/09031936.00003608 [DOI] [PubMed]
7. Lacoma A, Prat C, Andreo F, Lores L, Ruiz-Manzano J, Ausina V, et al. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011; 6: 157-69. doi: 10.2147/COPD.S16070 [DOI] [PubMed]
8. Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med. 2008 Apr; 36(4): 1147-54. doi: 10.1097/CCM.0b013e3181692966 [DOI] [PubMed]
9. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007 Mar; 7(3): 210-17. doi: 10.1016/S1473-3099(07)70052-X [DOI] [PubMed]
10. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care. 2006; 10(5): R125. doi: 10.1186/cc5036 [DOI] [PubMed]
11. Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009 Dec; 34(6): 1364-75. doi: 10.1183/09031936.00053209 [DOI] [PubMed]
12. Bruun T, Loewer HL. Prevalence surveillance system of nosocomial infections in Norway. Euro Surveill. 2007 Aug; 12(8): E070830.2. doi: 10.2807/esw.12.35.03258-en [DOI] [PubMed]
13. Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA. 2013 Feb; 309(7): 717-18. doi: 10.1001/jama.2013.697 [DOI] [PubMed]
14. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010 Jan; 50(2): 202-209. doi: 10.1086/648678 [DOI] [PubMed]
15. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb; 171(4): 388-416. doi: 10.1164/rccm.200405-644ST [DOI] [PubMed]
16. Martin-Loeches I, Povoa P, Rodríguez A, Curcio D, Suarez D, Mira JP, Cordero ML, et al. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study. Lancet Respir Med. 2015 Nov; 3(11): 859-68. doi: 10.1016/S2213-2600(15)00326-4 [DOI] [PubMed]
17. Ko M, Lee Y, Chen C, Chou P, Chu D. Prevalence of and Predictors for Frequent Utilization of Emergency Department: A Population-Based Study. Medicine (Baltimore). 2015 Jul; 94(29): e1205. doi: 10.1097/MD.0000000000001205 [DOI] [PubMed]
18. Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care. 2010; 14(1): 203. doi: 10.1186/cc8155 [DOI] [PubMed]
19. Zielińska-Borkowska U, Skirecki T, Złotorowicz M, Czarnocka B. Procalcitonin in early onset ventilator-associated pneumonia. J Hosp Infect. 2012 Jun; 81(2): 92-97. doi: 10.1016/j.jhin.2012.02.011 [DOI] [PubMed]
20. Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med. 2008 Jul; 52(1): 48-58.e2. doi: 10.1016/j.annemergmed.2008.01.003 [DOI] [PubMed]
21. Chen C, Yan M, Hu C, Lv X, Zhang H, Chen S. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia. Med Sci (Paris). 2018 Oct; 34 Focus issue F1: 26-32. doi: 10.1051/medsci/201834f105 [DOI] [PubMed]
22. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J. 2005 May; 25(5): 804-12. doi: 10.1183/09031936.05.00071704 [DOI] [PubMed]
23. Hillas G, Vassilakopoulos T, Plantza P, Rasidakis A, Bakakos P. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J. 2010 Apr; 35(4): 805-11. doi: 10.1183/09031936.00051309 [DOI] [PubMed]
24. Mourad S, Rajab M, Alameddine A, Fares M, Ziade F, Merhi BA. Hemoglobin level as a risk factor for lower respiratory tract infections in Lebanese children. N Am J Med Sci. 2010 Oct; 2(10): 461-66. doi: 10.4297/najms.2010.2461 [DOI] [PubMed]
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mousavi S R, Deylami M, Azarhoush R, Ghourchaei A, Kazemnejad K, Mojaveraghili S, et al . Prevalence of Ventilator-Associated Pneumonia and Evaluation of Serum C-Reactive Protein, Hemoglobin, and Procalcitonin Levels as their Biomarkers Among Brain Trauma Patients in 5th Azar Hospital, Gorgan, Iran. J Gorgan Univ Med Sci 2022; 24 (4) :85-90
URL: http://goums.ac.ir/journal/article-1-4065-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 4 (12-2022) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4645